fbpx

Advanced Radiation Therapy Announces the Launch of PreciseRT™

preciseRT

PreciseRT™ has been launched in the U.S. MedTech marketplace and is available to radiation therapy clinics and hospitals immediately.

“We have been developing this technology for some time now and have designed it to meet the clinical challenges of treating breast cancer with radiation in ways which optimize the cosmetic and clinical outcomes in consideration of the adjuvant surgical techniques commonly employed today,” says Piran Sioshansi, President and CEO of Advanced Radiation Therapy (ART).

By leveraging the imaging quality of breast diagnostic technology, PreciseRT provides radiation oncologists with high-resolution images in real-time allowing them to both easily identify the tumor bed and treat patients quickly on a single platform. This approach provides a means to treat patients efficiently and can be deployed to maximize the ability to treat in a hypofractionation environment. In the new world of COVID-19 and considering reimbursement changes in the U.S. providing radiation oncology centers this clinical and operational flexibility is the right response.

Bill Dowd, Chief Commercialization Officer at ART, commented that “PreciseRT is the right product for this market at the right time. Approximately 12% of women will be diagnosed with breast cancer in their lifetime so novel technologies like this one are in ever-increasing demand as our population becomes larger and grows older.”

About Advanced Radiation Therapy (ART)
Advanced Radiation Therapy, headquartered outside of Boston, MA, is an innovator in precision radiation therapy for breast cancer and developed multiple non-invasive breast brachytherapy treatments (NIBB).

For more information visit http://www.PreciseRT.com and on LinkedIn.

For more information contact Bill Dowd (Bill.Dowd@artcorporation.net | 978-649-0007)